D. Mirchandani

Fulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032

James N. Ingle, Vera J. Suman, Kendrith M. Rowland et al. · Journal of Clinical Oncology · 2006 · 151 citations · Full text

Medicine, Oncology, Pharmacology +17

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.

D. Mirchandani, Jianping Zheng, Gary J. Miller et al. · PubMed · 1995 · 122 citations

Medicine, Genetics, Oncology +16

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer

Eleni Andreopoulou, Darci Gaiotti, E. Kim et al. · Annals of Oncology · 2007 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Neoadjuvant Chemotherapy Followed by Surgery for Advanced-Stage Endometrial Cancer

Norbert Lange, N Ezendam, Janice S. Kwon et al. · Current Oncology · 2019 · 50 citations · Full text

Medicine, Oncology, Surgery +17

Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.

Raymond Osborne, Allan Covens, D. Mirchandani et al. · PubMed · 2004 · 38 citations

Medicine, Oncology, Pharmacotherapy +11